4 results about "Cartilage cells" patented technology

The application provides yak cartilage peptide with a function of repairing cartilage injury, and a preparation method and application thereof, and belongs to the technical field of active peptides. The application selects crescent bones of yaks as raw materials, adopts papain and trypsin for complex enzymolysis, and combines with ultrasonic-assisted enzymolysis technology, so that the enzymolysis efficiency and peptide yield are greatly improved. The yak cartilage peptide prepared by the application is proved to have good antioxidant activity and the effect of promoting cartilage cell proliferation through in-vitro cell experiments, and the effect is significantly better than that of traditional enzymolysis methods and commercial pig bone peptide, fetal bovine bone peptide and other products. Therefore, the yak cartilage peptide prepared by the application can be used for repairing cartilage injury, treating cartilage degeneration and improving symptoms related to osteoarthritis.

The application provides a developmental growth plate layered scaffold and a preparation method and application thereof, and belongs to the technical field of bone tissue engineering materials. The developmental growth plate layered scaffold provided by the application is divided into three layers, the upper layer is a cartilage cell layer, the middle layer is a blood vessel barrier layer, and the lower layer is a bone formation layer. The blood vessel barrier layer can be used as biological glue to bond the upper layer and the lower layer, so that the composite scaffold structure is stable and is not easy to break; and the upper layer contains bone marrow mesenchymal stem cells (BMSCs), and the middle layer and the lower layer are cell-free. Under the in-vitro chondrogenic induction culture condition, the BMSCs in the upper layer can pass through the middle layer and colonize in the lower layer, and in the process, part of the BMSCs can differentiate into cartilage cells. The middle layer containing thrombospondin 1 (TSP1) has specific intervention effect on cell migration, which is manifested as inhibition of the migration of vascular endothelial cells, but has no effect on the migration of BMSCs.

The present application relates to a kind of mussel mucus-based cartilage repair material, the material includes mussel mucus complex coacervate and bioactive ingredient, the swelling rate of the repair material is controlled at 21.5%~80%, and the adhesion strength is 60.5~140.8kPa, the mussel mucus complex coacervate includes mussel mucus and material A capable of electrostatically combined with the mussel mucus;The material A is at least one of polyanion material, amphiphilic polyelectrolyte material.The mussel mucus-based cartilage repair material of the present application has suitable mechanical strength, excellent wet adhesion performance and good biocompatibility;It is also beneficial to cartilage cell survival and function maintenance, and promote the integration of new tissue and host cartilage, suitable for in situ repair of articular cartilage defect.

The application relates to a biological 3D printing cartilage-fiber-epithelium integrated tissue engineering trachea and a construction method and application thereof. First, cartilage specific biological ink is prepared by wrapping cartilage cells with cartilage tissue specific hydrogel; fiber specific biological ink is prepared by wrapping fibroblasts with fiber tissue specific hydrogel; epithelium specific biological ink is prepared by wrapping epithelial cells with matrix hydrogel; then, through a step-by-step assembly strategy, a C-shaped cartilage ring and a fiber ring are alternately printed and a ring-shaped tubular structure is formed by using a double-needle extrusion type biological 3D printing technology, and then a layer of epithelium specific biological ink is attached in the lumen to construct a tubular structure of cartilage-fiber-epithelium multi-tissue composite; it is verified that after being implanted subcutaneously in a naked mouse for 8 weeks, a relatively mature cartilage-vascularized fiber-epithelium tissue composite tissue engineering trachea can be regenerated, and a clinically transformable strategy is provided for the regeneration treatment of complex tracheal injury.